Nanjing Bio-sci Pharmaceutical

Nanjing Bio-sci Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. The company focuses primarily on chronic disease management, with a strong portfolio in metabolic disorders such as type 2 diabetes and cardiovascular conditions like hypertension. Nanjing Bio-sci operates advanced manufacturing facilities that comply with international GMP standards, enabling it to serve both domestic and global markets. By integrating R&D with large-scale production, the company aims to provide affordable and effective therapeutic solutions for widespread health challenges.